CONSOLIDATED STATEMENTS OF INCOME (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2012		Jun. 30, 2011	Jun. 30, 2012		Jun. 30, 2011
Net sales	$ 684,894		$ 742,108	$ 1,396,598		$ 1,438,638
Cost of goods sold	442,209		490,159	906,026		953,673
Gross profit	242,685		251,949	490,572		484,965
Selling, general and administrative expenses (Note 13)	74,624		82,907	155,316		155,946
Research and development expenses	20,911		19,947	39,960		37,562
Restructuring and other charges	94,703	[1]		94,703	[1]
Operating profit	52,447		149,095	200,593		291,457
Interest and financing expenses	(8,486)		(9,274)	(17,220)		(18,866)
Other expenses, net	(688)		(760)	(806)		(422)
Income before income taxes and equity in net income of unconsolidated investments	43,273		139,061	182,567		272,169
Income tax expense	14,747		30,154	50,213		62,326
Income before equity in net income of unconsolidated investments	28,526		108,907	132,354		209,843
Equity in net income of unconsolidated investments (net of tax)	12,712		14,787	21,298		27,618
Net income	41,238		123,694	153,652		237,461
Net income attributable to noncontrolling interests	(3,506)		(9,535)	(7,877)		(16,722)
Net income attributable to Albemarle Corporation	$ 37,732		$ 114,159	$ 145,775		$ 220,739
Basic earnings per share	$ 0.42		$ 1.24	$ 1.63		$ 2.41
Diluted earnings per share	$ 0.42		$ 1.23	$ 1.62		$ 2.38
Weighted-average common shares outstanding - basic	89,414		91,713	89,206		91,673
Weighted-average common shares outstanding - diluted	90,051		92,795	89,999		92,656
Cash dividends declared per share of common stock	$ 0.200		$ 0.165	$ 0.400		$ 0.330

[1] The three-month and six-month periods ended June 30, 2012 include charges amounting to $94,703 ($73,590 after income taxes) in connection with our exit of the phosphorous flame retardants business.